Author

B. H. Liu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Organism:bacteria (other)· 1 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1

Frequent Co-Authors

C. Gao· 2 shared D. G. Tenen· 2 shared F. Li· 2 shared H. Arthanari· 2 shared J. Qi· 2 shared K. Kumari· 2 shared M. Liu· 2 shared X. Tian· 2 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Gao

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Targeting transcription factors through an IMiD independent zinc finger domain

B. H. Liu, M. Liu, S. Radhakrishnan, C. K. Jaladanki, C. Gao, J. Tang, K. Kumari, M. L. Go, K. A. Vu Le, H.-S. Seo, K. Song, X. Tian, F. Li, J. Tan, H. Arthanari, , C. Li

This study identifies a new IMiD-independent drug targeting SALL4's ZFC4 domain, leading to significant tumor growth inhibition in vivo.

bioRxiv · Jan 3, 2024Cancer Biology

SALLB not targeted by IMiDs is important for maintenance of liver cancer cells

K. A. L. Vu, S. Moein, K. Kumari, B. H. Liu, C. Gao, M. Liu, M.-Y. Dai, Z. Liu, F. Li, J. P. Tang, D. Maddalo, D. S. Auld, D. E. Casalena, X. Tian, M. A. Bassal, , L. Chai

The paper identifies a compound that degrades both SALL4 isoforms, overcoming IMiD limitations in liver cancer treatment.

bioRxiv · Jul 7, 2023 · PreprintCancer Biology

How formate dehydrogenase-lacking acetogen Clostridium bovifaecis utilize formate as the sole carbon source for its acetogenic growth?

Z. W. Guan, B. Fu, R. Conrad, Q. Q. Qian, D. Han, B. H. Liu, H. Liu

This study investigates how Clostridium bovifaecis, an FDH-lacking acetogen, uses formate as the sole carbon source for acetogenesis by converting it to acetate with a 2.0:1 to 2.6:1 molar ratio.

bioRxiv · Jun 12, 2023 · PreprintMicrobiology